GEMCITABINE-PRODRUGS

European patent · EP3757112 · Deleted

Register entry

Publication number
EP3757112
Application number
EP20187951
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jun 25, 2015
Published
Dec 30, 2020
Granted
Jun 7, 2023
Deleted
Jan 25, 2025
Reason
Annual fee unpaid
IPC classes
C07H 19/10 (2006.01)
A61K 31/7068 (2006.01)
A61P 35/00 (2006.01)
A61K 9/00 (2006.01)
A61K 47/16 (2006.01)
A61K 47/20 (2006.01)
A61K 47/22 (2006.01)
A61K 9/08 (2006.01)
Priority
GB 201411253 25.06.2014
IN 2050MU2014 25.06.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 25, 2025

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    25.01.2025
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 25.01.2025

  2. Apr 24, 2024

    Change

    Published in Swissreg on 24.04.2024

  3. Apr 17, 2024

    Change

    Published in Swissreg on 17.04.2024

  4. Sep 11, 2023

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 11.09.2023

  5. Jul 12, 2023

    Change

    Published in Swissreg on 12.07.2023

  6. Jun 7, 2023

    Granted

    Published in Swissreg on 07.06.2023

Parties

Holder

Nucana PLC

3 Lochside Way, Edinburgh EH12 9DT, GB

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

FERRARI, Valentina

Ramsgate, Kent CT11 9NS, GB

MCGUIGAN, Christopher

deceased, GB

SLUSARCZYK, Magdalena

Cardiff, South Glamorgan CF10 3NB, GB

SERPI, Michaela

Cardiff, South Glamorgan CF10 3NB, GB

GRIFFITH, Hugh

Edinburgh, Scotland EH12 9DT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.